Timothy Power | VP & Head, IR |
Giovanni Caforio | Chairman & CEO |
David Elkins | EVP & CFO |
Christopher Boerner | EVP & Chief Commercialization Officer |
Adam Lenkowsky | Chief Commercialization Officer |
Samit Hirawat | EVP & Chief Medical Officer, Global Drug Development |
Chris Shibutani | Goldman Sachs |
Evan Seigerman | BMO Capital Markets |
Geoff Meacham | Bank of America |
Terence Flynn | Morgan Stanley |
Chris Schott | JPMorgan |
Seamus Fernandez | Guggenheim |
Carter Gould | Barclays |
Timothy Anderson | Wolfe Research |
Steve Scala | TD Cowen |
Matthew Phipps | William Blair |
David Risinger | Leerink Partners |
Mohit Bansal | Wells Fargo |
Yihan Li | UBS |
Dane Leone | Raymond James |
Olivia Brayer | Cantor Fitzgerald |
Good morning, everyone. Welcome to the Bristol-Myers Squibb Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask question. [Operator Instructions] Please also note, today's event is being recorded.